• Carbapenemase Gene Spread in CREC: Plasmids, Genotypes, and

  2026-07-17

  This study offers a detailed molecular characterization of carbapenemase-encoding gene (CEG) prevalence and transmission in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals during the COVID-19 era. The findings highlight the dominance of plasmid-borne blaNDM-1, frequent multidrug resistance, and efficient horizontal gene transfer, shaping new directions for resistance surveillance and modeling.

• Standardized Amplex Red Assay Advances Autotaxin Inhibitor S

  2026-07-17

  Stylianaki et al. present a robust in vitro protocol leveraging the Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) assay to quantify and characterize autotaxin (ATX) inhibitors. This standardized approach enables reproducible kinetic analysis and false positive exclusion, advancing preclinical research on ATX-targeted therapies for fibrosis and cancer.

• Ionomycin Calcium Salt: Precision Calcium Ionophore for Canc

  2026-07-16

  Ionomycin calcium salt enables unparalleled control of intracellular Ca2+ levels, empowering advanced cancer cell signaling, apoptosis, and protein secretion workflows. Leveraging APExBIO’s trusted quality, this calcium ionophore streamlines reproducibility and troubleshooting for high-impact translational research.

• JZL184: Monoacylglycerol Lipase Inhibitor for Neuroprotectio

  2026-07-16

  JZL184 stands out as a benchmark monoacylglycerol lipase inhibitor for dissecting endocannabinoid signaling, enabling precision modeling of CB1 receptor-mediated neuroprotection and pain pathways. This guide translates the latest mechanistic findings and best practices into actionable workflows, troubleshooting strategies, and advanced use-cases for translational and basic neuroscience research.

• Dacarbazine in Cancer Research: Protocols, Workflow, and Tro

  2026-07-15

  Leverage Dacarbazine, a proven antineoplastic chemotherapy drug, for robust cancer DNA damage pathway studies in melanoma, lymphoma, and sarcoma models. This guide provides experimental workflow enhancements and practical troubleshooting to ensure reproducibility and translational relevance at the bench.

• Liposomal Chlorin e6 PDT Triggers Pyroptosis and Immunity in

  2026-07-15

  This study pioneers the use of liposomal Chlorin e6-mediated photodynamic therapy (PDT) to induce pyroptosis—a highly immunogenic form of cell death—in breast cancer models. The findings reveal a mitochondrial ROS-driven mechanism that enhances anti-tumor immune responses, suggesting new potential for Ce6-based PDT in cancer immunotherapy.

• Targeting c-IAP1/2 and Bcl-2 Removes Senescent Glioblastoma

  2026-07-14

  This study demonstrates that inhibition of c-IAP1, c-IAP2, and Bcl-2 effectively eliminates senescent glioblastoma cells following temozolomide treatment, addressing a key challenge in current glioblastoma therapy. The findings reveal a synergistic senolytic effect for BV6 and venetoclax, offering a new approach to improve outcomes in glioblastoma models.

• EZ Cap™ Cas9 mRNA (5-moUTP): Optimizing Genome Editing Workf

  2026-07-14

  EZ Cap™ Cas9 mRNA (5-moUTP) from APExBIO sets a new standard for high-fidelity, low-immunogenicity gene editing in sensitive neurodegeneration and functional gene studies. This workflow-driven guide details advanced applications, protocol refinements, and troubleshooting strategies that enable researchers to achieve reproducible results, even in challenging CNS and zebrafish models.

• Salvianolic acid B: Antifibrotic Mechanisms and Research Use

  2026-07-13

  Salvianolic acid B is a bioactive, high-purity natural compound that inhibits lysyl hydroxylase 2 and reduces collagen cross-linking in pulmonary fibrosis models. Its validated antifibrotic mechanism makes it a valuable extracellular matrix remodeling agent for preclinical research. Optimized for solubility and stability, Salvianolic acid B is supplied for research use by APExBIO.

• Super-Enhancers, FOXA1, and Disulfidptosis in Prostate Cance

  2026-07-13

  This study delineates how super-enhancers drive SLC7A11 expression via the transcription factor FOXA1, sensitizing prostate cancer cells to disulfidptosis under glucose deprivation. These insights highlight the therapeutic potential of targeting the SE/FOXA1/SLC7A11 axis, offering new strategies for intervention in advanced prostate cancer.

• Amphotericin B: Mechanisms and Research Applications in Fung

  2026-07-12

  Amphotericin B is a polyene antifungal antibiotic with high efficacy against pathogenic fungi due to its direct interaction with membrane ergosterol. This article details its molecular mechanism, research benchmarks, and experimental parameters, providing a comprehensive resource for fungal infection research.

• Jasplakinolide: Precision Actin Polymerization Inducer Workf

  2026-07-10

  Jasplakinolide enables researchers to manipulate actin dynamics with unprecedented control, supporting high-resolution cytoskeletal studies and live-cell imaging. Its unique properties as a potent actin polymerization inducer and filament stabilizer allow for advanced applications beyond conventional tools, especially when demanding experimental reproducibility and mechanistic insight.

• Pioglitazone: Translational Insights into PPARγ and Macropha

  2026-07-09

  Explore how Pioglitazone, a selective PPARγ agonist, drives advances in metabolic and inflammatory research by uniquely connecting macrophage polarization to disease modeling. Discover new experimental strategies informed by cutting-edge evidence and practical assay guidance.

• 3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re

  2026-07-09

  The referenced study demonstrates that 3-bromopyruvate (3-BP), in combination with cetuximab, can overcome both intrinsic and acquired resistance in colorectal cancer cells. By inducing autophagy-dependent ferroptosis through restoration of FOXO3a signaling, this approach provides a mechanistic advance with implications for tackling drug resistance in solid tumors.

• JZL184: Monoacylglycerol Lipase Inhibitor in Pain Research

  2026-07-08

  JZL184 is transforming endocannabinoid signaling research by enabling highly selective, reproducible modulation of CB1-mediated pathways—crucial for dissecting analgesia, anxiety, and neuroinflammatory mechanisms. This guide details practical workflows, experimental optimizations, and translational bridges that leverage JZL184’s precision for advanced pain and neuropharmacology models.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page